Document Type : Case Report


1 General Surgery Department, Hospital General de Zona 5, Instituto Mexicano del Seguro Social, Sonora, Mexico

2 Hematology Department, Hospital General de Zona 5, Instituto Mexicano del Seguro Social, Sonora, Mexico

3 Pathology Department, Hospital General de Zona 5, Instituto Mexicano del Seguro Social, Sonora, Mexico



Introduction: Burkitt lymphoma is an aggressive subtype of Hodgkin lymphoma with a doubling time of 25 hours. It is characterized by a MYC gene coding alteration which results from a translocation of chromosome 8 on the MYC gene locus and immunoglobulin heavy-chain locus (IGH) on chromosome 14. Even though HIV infection is associated to an increased risk of Burkitt lymphoma, these type of malignancies are EBV-negative cases. Sporadic type Burkitt lymphoma is a rare clinical entity.
Case Presentation: A 48-year-old female without any past medical history presented with a chief complaint of mild abdominal pain of 6 months duration located at the epigastrium which was not related to food ingestion. Nausea or vomiting were neither reported. She noted an acute increased abdominal pain over the last 4 hours before presentation, with irradiation to the right lower quadrant. She denied any Fever, night sweats and weight loss. She also reported hypermenorrhea in the last 6 months. During the physical examination, a palpable mass with 10 cm in diameter was found on right lower quadrant.
Conclusion: Sporadic Burkitt lymphoma is one of the rarest hematologic malignancies. The increased tumor size may be more than enough to show clinical or biochemical abnormalities such as serum lactate dehydrogenase (LDH) increased and tumor lysis.


  1. Jacobson C, LaCasce A. How I treat Burkitt lymphoma in adults. Blood. 2014;124(19):2913-2920. doi:10.1182/ blood-2014-06-538504.
  2. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
  3. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390. doi:10.1182/ blood-2016-01-643569.
  4. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265-276. doi:10.1182/blood-2005-06-2508.
  5. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol. 1998;16(8):2780-2795. doi:10.1200/JCO.1998.16.8.2780.
  6. Robbiani DF, Deroubaix S, Feldhahn N, et al. Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma. Cell. 2015;162(4):727-737. doi:10.1016/j.cell.2015.07.019.
  7. Bishop PC, Rao VK, Wilson WH. Burkitt’s lymphoma: molecular pathogenesis and treatment. Cancer Invest. 2000;18(6):574- 583. doi:10.3109/07357900009012197.
  8. Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105(11):1684-1692. doi:10.1038/bjc.2011.450.
  9. Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010;362(15):1417-1429. doi:10.1056/NEJMra0807082.
  10. Stepniak A, Czuczwar P, Szkodziak P, Wozniakowska E, Wozniak S, Paszkowski T. Primary ovarian Burkitt’s lymphoma: a rare oncological problem in gynaecology: a review of literature. Arch Gynecol Obstet. 2017;296(4):653-660. doi:10.1007/s00404-017-4478-6.
  11. Aslan G. Unusual presentation of sporadic Burkitt’s lymphoma originating from the nasal septum: a case report. J Med Case Rep. 2013;7:60. doi:10.1186/1752-1947-7-60.
  12. Patankar S, Venkatraman P, Sridharan G, Kane S. Burkitt’s lymphoma of maxillary gingiva: A case report. World J Clin Cases. 2015;3(12):1011-1016. doi:10.12998/wjcc.v3.i12.1011.